Table 5.
Symbol | Fold Change | Description |
ABCA1 | 1.8 | ATP-binding cassette, sub-family A (ABC1), member 1 |
ABCC3 | 1.7 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
AIM2 | 1.6 | Related to IFI16 |
ARRB1 | 1.7 | arrestin, beta 1 |
C1QA | 1.6 | complement component 1, q subcomponent, A chain |
C1QB | 2.0 | complement component 1, q subcomponent, B chain |
CALML4 | 1.8 | calmodulin-like 4 |
CDKN1C | 2.2 | cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
CMKLR1 | 2.0 | chemokine-like receptor 1, chimerin |
CTSL1 | 2.4 | cathepsin L1 (lysosomal cysteine proteinase) |
CUTL1 | 1.5 | cut-like 1, CCAAT displacement protein (Drosophila) |
CXCL10 | 4.0 | chemokine (C-X-C motif) ligand 10 |
FAM46A | 1.6 | family with sequence similarity 46, member A |
FFAR2 (GPR43) | 2.7 | free fatty acid receptor 2. |
hCG_1776259 | 1.9 | hypothetical protein FLJ23556 (unknown function) |
IL1RN | 2.1 | interleukin 1 receptor antagonist |
JAK2 | 1.7 | Janus kinase 2 (a protein tyrosine kinase) |
LILRA3 | 1.6 | leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 |
MARCKS | 2.4 | myristoylated alanine-rich protein kinase C substrate |
RHOB | 1.7 | ras homolog gene family, member B |
RRAS | 1.9 | related RAS viral (r-ras) oncogene homolog |
SAMD4A | 2.6 | sterile alpha motif domain containing 4A |
SLC31A2 | 1.7 | solute carrier family 31 (copper transporters), member 2 |
TCN2 | 2.2 | transcobalamin II; macrocytic anemia |
TLR1 | 1.6 | toll-like receptor 1 |
TNFAIP6 (TSG-6) | 2.1 | tumor necrosis factor, alpha-induced protein 6 |
TNFSF10 (TRAIL) | 2.3 | tumor necrosis factor (ligand) superfamily, member 10 |
TRAFD1 (FLN29) | 2.0 | TRAF-type zinc finger domain containing 1 |
VDR | 1.6 | vitamin D (1,25- dihydroxyvitamin D3) receptor |
Genes are significantly induced at day 3 but either not induced at any other time point, or day 3 fold change is at least 20% higher than other days.